Testing a new system for treating atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if this approach is safe and effective for people with AF that comes and goes or lasts for a short time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with symptomatic atrial fibrillation that either comes and goes or is persistent.
- You have tried at least one heart rhythm medication and it didn't work or you couldn't tolerate it.
- Your atrial fibrillation has not lasted continuously for more than 12 months.
- You have not had a stroke or other blood clot event in the past 6 months.
- You have not had a heart attack or heart procedure (like a stent) in the past 3 months.
- You have not had any prior surgery or ablation on the left upper chamber of your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a newer ablation procedure (PulseSelect) to treat atrial fibrillation—a common heart rhythm problem. The goal is to see if this optimized workflow helps patients have fewer symptoms and better outcomes.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
This trial tests a new device, the Globe® Pulsed Field System, to treat people with paroxysmal atrial fibrillation (AFib) that comes and goes and causes symptoms, especially if standard medications haven't worked or caused side effects. It's designed to see if this system is a safe and effective option for you.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.